The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.
Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern
The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.